Insider Transactions in Q1 2025 at Singular Genomics Systems, Inc. (OMIC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,107
+0.77%
|
-
|
|
Feb 14
2025
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,107
-77.3%
|
-
|
|
Feb 14
2025
|
Andrew Spaventa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
800
-35.84%
|
$15,200
$19.89 P/Share
|
|
Feb 12
2025
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,907
+46.07%
|
-
|
|
Feb 09
2025
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.32%
|
-
|
|
Feb 09
2025
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+5.0%
|
-
|
|
Feb 09
2025
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+7.08%
|
-
|
|
Jan 02
2025
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+12.09%
|
-
|